Editorials |
From the NMR Laboratory for Physiological Chemistry, Division of Cardiovascular Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Rong Tian, MD, PhD, 221 Longwood Ave, Room 252, Boston, MA 02115. E-mail rtian@rics.bwh.harvard.edu
See related article, pages 180188
Key Words: insulin signaling Akt phosphorylation ß-adrenergic stimulation
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Insulin is the most potent anabolic hormone and is essential for tissue development, growth, and maintenance of whole-body glucose homeostasis. Failure of the target cells to respond to insulin stimulation, ie, insulin resistance, is commonly observed under acute stress conditions and in individuals with obesity, metabolic syndrome, or diabetes. Insulin resistance has been considered a major risk factor for the development and progression of cardiovascular disease.1,2 Although a well-documented phenomenon, the molecular mechanisms leading to insulin resistance remain elusive, attributable, in part, to the complexity of the insulin signaling pathway.
Circulating insulin binds to and activates its cell surface receptor to elicit its biological actions (Figure). The insulin receptor is a widely expressed transmembrane tyrosine kinase consisting of two
- and two ß-subunits.3,4 The binding of insulin to the extracellular
-subunit results in a rapid configurational change in the receptor leading to the autophosphorylation of specific tyrosine residues of the intracellular region of the ß-subunit.5 This process results in activation of the tyrosine kinase activity of the insulin receptor, which transmits the insulin signal by phosphorylating a number of substrate proteins.5,6 The insulin-receptor signaling involves two major pathways: the mitogen activated protein kinase (MAPK) pathway, mainly responsible for mitogenesis and cell growth, and the phosphatidylinositol-3-kinase (PI3-K) pathways, mainly account for the metabolic responses (Figure; although depicted as linear pathways, these two systems also interact under certain conditions). A critical player in the PI3-K pathway is the Ser/Thr kinase Akt (PKB), which serves as a multifaceted intermediary
Related Article:
Circ. Res. 2005 96: 180-188.
This article has been cited by other articles:
![]() |
S. Banerjee, K. Saito, M. Ait-Goughoulte, K. Meyer, R. B. Ray, and R. Ray Hepatitis C Virus Core Protein Upregulates Serine Phosphorylation of Insulin Receptor Substrate-1 and Impairs the Downstream Akt/Protein Kinase B Signaling Pathway for Insulin Resistance J. Virol., March 15, 2008; 82(6): 2606 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Q. Zhao, F. G. De Felice, S. Fernandez, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein Amyloid beta oligomers induce impairment of neuronal insulin receptors FASEB J, January 1, 2008; 22(1): 246 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Deng, J.-P. Huang, L.-S. Lu, and L.-M. Hung Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H978 - H987. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |